• [1]
    Kotob, S.I., Coon, S.L., Quintero, E.J., Weiner, R.M. (1995) Homogentisic acid is the primary precursor of melanin synthesis in Vibrio cholerae, a Hyphomonas strain, and Shewanella colwelliana. Appl. Environ. Microbiol. 61, 16201622.
  • [2]
    Menon, I.A., Persad, S.D., Haberman, H.F., Basu, P.K., Norfray, J.F., Felix, C.C., Kalyanaraman, B. (1991) Characterization of the pigment from homogentisic acid and urine and tissue from alkaptonuria patient. Biochem. Cell. Biol. 69, 269273.
  • [3]
    Rippert, P., Scimemi, C., Dubald, M., Matringe, M. (2004) Engineering plant sikimate pathway for production of tocotrienol and improving herbicide resistance. Plant Physiol. 134, 19.
  • [4]
    Garrod, A.E. (1902) The incidence of alkaptonuria: a study on clinical individuality. Lancet 2, 16161620.
  • [5]
    La Du, B.N. (1995) Alkaptonuria. In: The Metabolic and Molecular Bases of Inherited Diseases (Scriver, C.R., Beaudet, A.L., Sly, W., Valle, D., Eds.), pp.1371–1386 McGraw-Hill, New York.
  • [6]
    Fernández-Cañon, J.M., Granadino, B., Beltrán-Valero deBernabé, D., Renedo, M., Fernández-Ruiz, E., Peñalva, M.A., Rodríguez de Cordoba, S. (1996) The molecular basis of alkaptonuria. Nat. Genet. 14, 1924.
  • [7]
    Fernández-Cañon, J.M., Peñalva, M.A. (1995) Molecular characterization of a gene encoding a homogentisate dioxygenase from Aspergillus nidulans and identification of its human and plant homologues. J. Biol. Chem. 270, 2119921205.
  • [8]
    Arias-Barrau, E., Olivera, E.R., Luengo, J.M., Fernández, C., Galán, B., García, J.L., Díaz, E., Miñambres, B. (2004) The homogentisate pathway: A central catabolic pathway envolved in the degradation of l-phenylalanine, l-tyrosine, and 3-hydroxyphenylacetate in Pseudomonas putida. J. Bacteriol. 186, 50625077.
  • [9]
    García, B., Olivera, E.R., Sandoval, A., Arias-Barrau, E., Arias, S., Naharro, G., Luengo, J.M. (2004) Strategy for cloning large gene assemblages as illustrated using the phenylacetate and polyhydroxyalkanoate gene clusters. Appl. Environ. Microbiol. 70, 50195025.
  • [10]
    Herrero, M., de Lorenzo, V., Timmis, K.N. (1990) Transposon vectors containing non-antibiotic resistance selection markers for cloning and stable chromosomal insertion of foreign genes in Gram-negative bacteria. J. Bacteriol. 172, 65576567.
  • [11]
    Shäfer, A., Tauch, A., Jäger, W., Kalinowski, J., Tierbach, G., Pühler, A. (1994) Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. Gene 145, 6973.
  • [12]
    Quant, J., Hynes, M.F. (1983) Versatile suicide vectors which allow direct selection for gene replacement in Gram-negative bacteria. Gene 127, 1521.
  • [13]
    Sambrook, J., Fritsch, E.F., Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, second ed. Cold Spring Harbor Laboratory Press, Plainview, New York.
  • [14]
    Sanger, F., Nicklen, S., Coulson, A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 54635467.
  • [15]
    Luengo, J.M., García, J.L., Olivera, E.R. (2001) The phenylacetyl-CoA catabolon: a complex catabolic unit with broad biotechnological applications. Mol. Microbiol. 39, 14341442.
  • [16]
    Donnenberg, M.S., Kaper, J.B. (1991) Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect. Inmun. 59, 43104317.
  • [17]
    Song, J., Jensen, R.A. (1996) PhhR, a divergently transcribed activator of the phenylalanine hydroxylase gene cluster of Pseudomonas aeruginosa. Mol. Microbiol. 22, 497507.
  • [18]
    Edwards, S.W., Knox, W.E. (1995) Enzymes involved in conversion of tyrosine to acetoacetate. Meth. Enzymol. 2, 287300.
  • [19]
    Fernández-Cañon, J.M., Peñalva, M.A. (1998) Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J. Biol. Chem. 273, 329337.
  • [20]
    Fernández-Cañon, J.M., Peñalva, M.A. (1995) Fungal metabolic model for human type I hereditary tyrosinemia. Proc. Natl. Acad. Sci. USA 92, 91329136.
  • [21]
    Grompe, M. (2001) The pathophysiology and treatment of hereditary tyrosinemia type I. Semin. Liver Dis. 21, 563571.
  • [22]
    Brownlee, J.M., Johnson-Winters, K., Harrison, D.H.T., Moran, G.R. (2004) Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC. Biochemistry 43, 63706377.
  • [23]
    Ling, T.-s., Shiu, S., Yang, D.-y. (1999) Design and synthesis of 3-fluoro-2-oxo-3-phenylpropionic acid derivatives as potent inhibitors of 4-hydroxyphenylpyruvate dioxygenase from pig liver. Bioorg. Med. Chem. 7, 14591465.
  • [24]
    Mitchell, G., Bartlett, D.W., Fraser, T.E., Hawkes, T.R., Holt, D.C., Townson, J., Wichert, R.A. (2001) Mesotrione: a new selective herbicide for use in maize. Pest. Manag. Sci. 57, 120128.
  • [25]
    Secor, J. (1994) Inhibition of barnyardgrass 4-hydroxyphenylpyruvate dioxygenase by sulcotrione. Plant. Physiol. 106, 14291433.
  • [26]
    Matringe, M., Sailland, A., Pelissier, B., Rolland, A., Zink, O. (2005) p-Hydroxyphenylpyruvate dioxygenase inhibitor-resistant plants. Pest. Manag. 61, 269276.